Coloplast revenue and financials
kr 418.80Change from previous close: +2.15%Absolute change: +kr 8.80
In the fiscal year ended September 2024, Coloplast reported revenue of kr 27.03B (+10.33% year over year). Net income was kr 5.05B, a net margin of 18.7%.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.33%
- FY to Sep 2024 vs FY to Sep 2023
- Net income growth
- +5.62%
- FY to Sep 2024 vs FY to Sep 2023
- Net margin
- 18.7%
- FY to Sep 2023: 19.5%
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 |
|---|---|---|---|
| Total assets | 48,073 | 48,159 | 37,446 |
| Current assets | 10,444 | 9,937 | 8,772 |
| Cash and equivalents | 788 | 911 | 414 |
| Short-term investments | — | — | 219 |
| Inventory | 3,672 | 3,522 | 3,187 |
| Net property, plant and equipment | 6,571 | 5,979 | 5,151 |
| Goodwill | 19,375 | 19,974 | 14,298 |
| Other intangible assets | 10,957 | 11,281 | 8,469 |
| Long-term investments | 74.0 | 65.0 | 51.0 |
| Current liabilities | 10,204 | 16,311 | 7,336 |
| Accounts payable | 1,519 | 1,294 | 1,242 |
| Long-term debt | 16,557 | 11,558 | 16,359 |
| Total debt | 22,629 | 19,567 | 18,708 |
| Total liabilities | 30,131 | 30,860 | 29,154 |
| Total equity (incl. minority) | 17,942 | 17,299 | 8,292 |
| Retained earnings | 15,391 | 14,632 | 5,386 |